Soothing the inflamed brain: antiinflammatories may be the first drugs to halt the progression of Alzheimer's
Article Abstract:
Researchers Patrick and Edith McGeer, both in their 70's, believe antiinflammatory drugs like dapsone may delay the progression of Alzheimer's disease. The accumulation of beta-amyloid and other substances in the brain induces an inflammatory immune process that destroys healthy brain cells. Dapsone will enter the second stage of clinical trials in late 2000, as early research has been promising.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Digital cinema is for reel
Article Abstract:
Digital projection performs well but its price is still too high to reach mainstream audiences in motion picture theaters.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Moviemaking in transition
Article Abstract:
Digital video cameras and new editing software are being used more in making fictional and documentary film making.
Publication Name: Scientific American
Subject: Science and technology
ISSN: 0036-8733
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Crystallized frameworks with giant pores: Are there limits to the possible? Microporous porphyrin solids
- Abstracts: India proposes private universities. India struggles to handle an embarrassment of riches. India cracks whip to end addiction to state funds
- Abstracts: Rethinking the telescope for a sharper view of the stars. Astronomers tame a workhorse laser. Laser pulses make fast work of an optical switch
- Abstracts: Chemokines take center stage in inflammatory ills. Mouse model for pregnancy problem? Systems for identifying new drugs are often faulty
- Abstracts: 1998 state elections: new players, same challenges. Observations from ASCE's first congressional fellow. The ethics of contributions